Disease activity and response to therapy monitored by [18F]FDG PET/CT using volume-based indices in IgG4-related disease.

Katsuya MitamuraHanae Arai-OkudaYuka YamamotoTakashi NorikaneYasukage TakamiKengo FujimotoRisa WakiyaHiroki OzakiHiroaki DobashiYoshihiro Nishiyama

Published in: EJNMMI research (2020)

[18F]FDG PET/CT is valuable for assessing the extent of multi-organ involvement before therapy and monitoring subsequent therapy in patients with IgG4-RD. [18F]FDG PET/CT using volumetric indices correlated with serum IgG4 and sIL-2R levels.

Keyphrases

disease activity
rheumatoid arthritis
systemic lupus erythematosus
rheumatoid arthritis patients
ankylosing spondylitis